When we assessed the association between each RS and the relevant clinical variables, we found that the RS was correlated with tumor volume for all three genetic mutations, suggesting that all the RS contain some information on tumor size (p-values were 0.03 for EGFR and <0.0001 for both KRAS and ALK, results not shown). The gene discussed is KRAS; the disease is neoplasm.